期刊文献+

Stro-1^+和Stro-1^-间充质干细胞免疫抑制作用机制的探讨 被引量:1

Studies on the molecular mechanism involved in different immunosuppressive effects between Stro-1^+ and Stro-1^- MSC
下载PDF
导出
摘要 目的探讨细胞因子(TGF-β1、IL-10)与Stro-1+、Stro-1-间充质干细胞(MSC)免疫抑制效应的相关性。方法采用实时定量RT-PCR比较TGF-β1、IL-10在MSC两种细胞亚群中的表达,以磷酸甘油醛脱氢酶(GAPDH)作为内参照。以Pri mer Expre-ssTM软件进行引物设计,以Ct表示PCR的相对产量,ΔCt代表靶基因与GAPDH之间的Ct之差,以2-ΔΔCt表示ΔCt(Stro-1+MSC)与ΔCt(Stro-1-MSC)之间的比值;在3种不同条件下[①MSC单独培养;②MSC与混合淋巴反应体系(MLR)直接接触;③MSC通过Transwell与MLR间接接触],用ELISA法检测Stro-1+与Stro-1-细胞培养上清中TGF-β1的表达。结果IL-10在Stro-1+与Stro-1-MSC中均低表达,而TGF-β1在Stro-1-MSC中显著高表达(P<0.05);ELISA结果显示在3种培养条件下,TGF-β1在Stro-1-MSC中的表达均显著高于Stro-1+MSC(P<0.05)。结论Stro-1+MSC较Stro-1-MSC免疫抑制作用更显著,其与TGF-β1和IL-10的表达无关,表明TGF-β1、IL-10在MSC不同亚群免疫抑制效应中不起主要作用。 Objective To evaluate whether TGF-β and IL-10, which are two well-known inhibitors of T-cell activation and proliferation, are involved in the difference of immunosuppressive effects between Stro-1 and Stro-1 mesenchymal stem cells (MSC). Methods Quantitative real time RT-PCR was performed to compare the expression levels of TGF-β1 and IL-10 genes between these two MSC subsets. Glyceraldehyde phosphate dehydrogenase (GAPDH) was used as internal reference. The sequences of the forward and reverse primers were designed with Primer ExpressTM software. Total RNA from Stro-1^+ and Stro-1^- cells was extracted after co-cultured with mixed lymphocyte reaction (MLR) system for 3 days. 1μg of total RNA was reversely transcribed into cDNA, and all reactions were performed in the ABI Prism 7700 Sequence Detection System. The relative quantity of PCR product was evaluated by Ct value. ACt represented the difference between the means of Ct (target gene) and Ct (GAPDH), while 2 , represented the ratio of ACt(Stro-1^+ MSC)/ACt(Stro-1 MSC). Furthermore, the protein content of TGF-β1 in the supernatants of 3 different settings (OMSC alone; (2)MSC plus MLR; (3)MSC plus MLR in Transwell system) were determined by enzyme-linked immunoassays (ELISA). Results The present study showed that low expression of IL-10 was detected in both subsets (Ct〉35), while the expression level of TGF-β1 in Stro-1 MSC was significant higher than that detected in Stro-1 MSC (2 = 0. 39, P(0. 05). In all the 3 different culture conditions, significantly higher expression of TGF-β1 was further detected in Stro-1 MSCs supernatant by ELISA assays (P(0. 05). Conclusion It is demonstrated that Stro-1 MSC has the more significantly immunosuppressive effect than Stro-1 MSC, whilst TGF-β1 and IL-10 do not, at least not dominant, thus contributes to the difference of the immunosuppressive effects between the MSC subsets.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2007年第11期1151-1153,共3页 Medical Journal of Chinese People's Liberation Army
关键词 间质干细胞 免疫抑制 转化生长因子Β1 白细胞介素10 mesenchymal stem cells immunosuppression transforming growth factor beta interleukin-10
  • 相关文献

参考文献9

  • 1Di Nicola M,Carlo-Stella C,Magni M,et al.Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.Blood,2002,99(10):3838.
  • 2Bartholomew A,Sturgeon C,Siatskas M,et al.Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.Exp Hematol,2002,30(1):42.
  • 3Tse WT,Pendleton JD,Beyer WM,et al.Suppression of allogeneic T-cell proliferation by human marrow stromal cells:implications in transplantation.Transplantation,2003,75(3):389.
  • 4Djouad F,Plence P,Bony C,et al.Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals.Blood,2003,102(10):3837.
  • 5张翼鷟,Loic Fouillard,Alain Chapel,Morad Bensidhoum,Christelle Mazurier,Aish Nasef,Sandrine Bouchet,Manuel Lopez,Dominique Thierry,Norbert Cclaucle Gorin,达万明.源于近端股骨间充质干细胞免疫抑制作用的研究[J].中华医学杂志,2005,85(39):2780-2784. 被引量:11
  • 6张翼鷟,达万明,赵丹丹,唐菊英.人间充质干细胞Stro-1^+和Stro-1^-亚群免疫抑制作用差异的体外研究[J].解放军医学杂志,2007,32(10):1040-1043. 被引量:3
  • 7Groux H,Bigler M,de Vries JE,et al.Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.J Exp Med,1996,184(1):19.
  • 8Gorelik L,Flavell RA.Abrogation of TGFbeta singaling in T cells leads to spontaneous T cell differentiation and autoimmune disease.Immunity,2000,12(2):171.
  • 9Boussiotis VA,Chen ZM,Zeller JC,et al.Altered T-cell receptor + CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-beta-treated alloreactive T cells that do not induce graft-versus-host disease.Blood,2001,97(2):565.

二级参考文献24

  • 1张翼鷟,Loic Fouillard,Alain Chapel,Morad Bensidhoum,Christelle Mazurier,Aish Nasef,Sandrine Bouchet,Manuel Lopez,Dominique Thierry,Norbert Cclaucle Gorin,达万明.源于近端股骨间充质干细胞免疫抑制作用的研究[J].中华医学杂志,2005,85(39):2780-2784. 被引量:11
  • 2Frassoni F LM, Bacigalupo A, Gluckman E. Expanded mesenchymal stem cells (MSC), coinfused with HLA identical hemaepoietic stem cell transplants, reduced acute and chronic graft versus host disease: a matched pair analysis [abstract]. Bone Marrow Transplant, 2002,29: 75.
  • 3Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet, 2004 ,363 :1439-1441.
  • 4Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science, 1999, 284:143-147.
  • 5Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol,2000,28:875-884.
  • 6Suva D, Garavaglia G, Menetrey J, et al. Non-hematopoietic human bone marrow contains long-lasting, pluripotential mesenchymal stem cells. J Cell Physiol,2004,198:110-118.
  • 7Gotherstrom C,Ringden O, Westgren M, et al. Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells. Bone Marrow Transplantation, 2003, 32: 265-272.
  • 8Fouillard L, Bensidhoum M, Bories D, et al. Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma. Leukemia, 2003,17:474-476.
  • 9Lee HS, Huang GT, Chiang H, et al. Multipotential mesenchymal stem cells from femoral bone marrow near the site of osteonecrosis. Stem Cells, 2003, 21: 190-199.
  • 10Zhao RC, Liao LM, Han Q. Mechanisms of and perspectives on the mesenchymal stem cell in immunotherapy. J Lab Clin Med, 2004,143:284-291.

共引文献10

同被引文献18

  • 1张翼鷟,Loic Fouillard,Alain Chapel,Morad Bensidhoum,Christelle Mazurier,Aish Nasef,Sandrine Bouchet,Manuel Lopez,Dominique Thierry,Norbert Cclaucle Gorin,达万明.源于近端股骨间充质干细胞免疫抑制作用的研究[J].中华医学杂志,2005,85(39):2780-2784. 被引量:11
  • 2Glennie S, Soeiro I, Dyson PJ, et al. Bone marrow mesenchymal stem cells induced division arrest anergy of activated T cells. Blood, 2005; 105(7): 2821 -2827.
  • 3Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 2005; 105 (4) : 1815 - 1822.
  • 4Bensidhoum M, Chapel A, Francois S, et al. Homing of in vitro expanded Stro-1^- or Stro-1^+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment. Blood, 2004; 103(9) : 3313 -3319.
  • 5Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol, 2002 ; 30 ( 1 ) : 42 - 48.
  • 6Corcione A, Benvenuto F, Ferretti E, et al. Human mesenchymal stem cells modulate B-cell functions. Blood, 2006; 107 (1) :367 -372.
  • 7Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 2002; 99 (10) :3838 -3843.
  • 8张翼鷟,达万明,赵丹丹,唐菊英.人间充质干细胞Stro-1^+和Stro-1^-亚群免疫抑制作用差异的体外研究[J].解放军医学杂志,2007,32(10):1040-1043. 被引量:3
  • 9危永基,林艳娟.间充质干细胞对各种免疫细胞的免疫调节作用的研究进展[J].中国实验血液学杂志,2010,18(4):1079-1083. 被引量:3
  • 10齐丙迪,孟宝玺,杨阳,刘蓓,李翅翅,夏炜,郭树忠,张晨.第三方骨髓间充质干细胞诱导同种异体移植受体免疫耐受机制的研究[J].中华整形外科杂志,2011,27(3):207-212. 被引量:9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部